Entering a New Era with the First Issue of 2026

Abstract

Dear readers,

We are pleased and honored to present the first issue of 2026 of European Journal of Therapeutics (EJT) to our readers. As the official scientific journal of Gaziantep Üniversitesi Tıp Fakültesi, we continue to pursue our mission of supporting high-quality scientific research across all fields of medicine and health sciences with determination.

As a result of systematic and dedicated efforts carried out throughout the past year, our journal has significantly increased its national and international visibility and academic impact. Indeed, the continuous increase in the number of submitted and published articles reflects the growing trust and recognition of our journal. EJT is indexed in the Web of Science – Emerging Sources Citation Index under the Medicine, General & Internal category and remains one of the limited number of medical faculty journals from Türkiye included in this index [1]. In addition, the Journal Impact Factor (JIF) of 0.4 for 2024 and its placement in the Q3 quartile in both JIF and Journal Citation Indicator (JCI) rankings reflect the growing scientific influence of our journal [2].

In this issue, we aim to shed light on contemporary scientific approaches through original research from various disciplines. Our commitment to ethical principles, impartial peer-review processes, and an academic quality-oriented approach continues to be among the core values of our journal.

We sincerely thank all our authors, reviewers, editors, and editorial board members whose contributions have made this success possible. We believe that by maintaining international publishing standards, we will continue to contribute to scientific knowledge in the coming years.

We hope that 2026 will be a year in which scientific collaborations are strengthened, productivity is enhanced, and academic sharing increases. We extend our sincere gratitude to our valued readers and all stakeholders who contribute to our journal.

Sincerely,